Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
4.400
-0.280 (-5.98%)
At close: Dec 5, 2025, 4:00 PM EST
4.470
+0.070 (1.59%)
After-hours: Dec 5, 2025, 4:47 PM EST
Orchestra BioMed Holdings Market Cap
Orchestra BioMed Holdings has a market cap or net worth of $248.44 million as of December 5, 2025. Its market cap has increased by 26.42% in one year.
Market Cap
248.44M
Enterprise Value
168.66M
1-Year Change
26.42%
Ranking
Category
Stock Price
$4.40
Market Cap Chart
Since August 4, 2020, Orchestra BioMed Holdings's market cap has increased from $197.44M to $248.44M, an increase of 25.83%. That is a compound annual growth rate of 4.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 248.44M | 63.39% |
| Dec 31, 2024 | 152.05M | -53.41% |
| Dec 29, 2023 | 326.34M | 191.65% |
| Dec 30, 2022 | 111.90M | -45.72% |
| Dec 31, 2021 | 206.14M | -21.31% |
| Dec 31, 2020 | 261.96M | 32.68% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |